These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 22109336)
1. Tolerability of gadobenate dimeglumine in a patient with reported allergy to gadoterate meglumine. Moulin C; Said BB; Berard F AJR Am J Roentgenol; 2011 Dec; 197(6):W1163. PubMed ID: 22109336 [No Abstract] [Full Text] [Related]
2. Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections. Abujudeh HH; Kosaraju VK; Kaewlai R AJR Am J Roentgenol; 2010 Feb; 194(2):430-4. PubMed ID: 20093606 [TBL] [Abstract][Full Text] [Related]
3. Incidence of immediate gadolinium contrast media reactions. Prince MR; Zhang H; Zou Z; Staron RB; Brill PW AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854 [TBL] [Abstract][Full Text] [Related]
5. Severe adverse reactions with contrast agents for magnetic resonance: clinical experience in 30,000 MR examinations. De Ridder F; De Maeseneer M; Stadnik T; Luypaert R; Osteaux M JBR-BTR; 2001 Aug; 84(4):150-2. PubMed ID: 11688727 [TBL] [Abstract][Full Text] [Related]
6. Frequency and Severity of Acute Allergic-Like Reactions to Intravenously Administered Gadolinium-Based Contrast Media in Children. Forbes-Amrhein MM; Dillman JR; Trout AT; Koch BL; Dickerson JM; Giordano RM; Towbin AJ Invest Radiol; 2018 May; 53(5):313-318. PubMed ID: 29337841 [TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. Knopp MV; Giesel FL; von Tengg-Kobligk H; Radeleff J; Requardt M; Kirchin MA; Hentrich HR J Magn Reson Imaging; 2003 Jun; 17(6):694-702. PubMed ID: 12766899 [TBL] [Abstract][Full Text] [Related]
17. Fatal reaction to gadopentetate dimeglumine. Jordan RM; Mintz RD AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905 [No Abstract] [Full Text] [Related]
18. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine. García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954 [No Abstract] [Full Text] [Related]
19. A Structured Survey on Adverse Events Occurring Within 24 Hours After Intravenous Exposure to Gadodiamide or Gadoterate Meglumine: A Controlled Prospective Comparison Study. Parillo M; Sapienza M; Arpaia F; Magnani F; Mallio CA; DʼAlessio P; Quattrocchi CC Invest Radiol; 2019 Apr; 54(4):191-197. PubMed ID: 30379729 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. Filippone A; Blakeborough A; Breuer J; Grazioli L; Gschwend S; Hammerstingl R; Heinz-Peer G; Kittner T; Laghi A; Leen E; Lencioni R; Lucidarme O; Remplik P; Robinson PJ; Ruehm SG; Schaefer F; Stoupis C; Tombach B; Valette PJ; Zech CJ; Huppertz A J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]